
Innovation Fund Spotlight: State-of-the-Art Genome Editing To Understand Disease and Develop New Therapies
Read ArticleBlog Posts focused on: Lab James; Eddie James, PhD

Interview with Dr. Megan Smithmyer: Type 1 Diabetes Biorepository (BRIDge Study)

Innovation Fund Spotlight: Lab-Grown Beta Cells Meet State-Of-The-Art Imaging To Answer New Questions About Type 1 Diabetes

BRI’s Innovation Fund Sparks New Discoveries

New Frontiers in Immunology: Studying Diseases in the Tissues Where They Happen

To Belgium and Back Again to Study Beta Cells

An Unprecedented Way To Study Rheumatoid Arthritis
The first symptoms Linda Sloate experienced were aching hands and pain that shot up her arms. She had carpal tunnel surgery in both hands. Then she felt pain in her feet while she was teaching kindergarten and running around after her three children.

Understanding What Causes IBD
James Lord, MD, PhD, has a simple way of explaining the immune system. “It’s not a homogenous pot of stew,” he says. “It’s a carefully orchestrated dance, and doing the right thing at the right time is critical. But it’s very hard to predict the choreography.”

Volunteering in a COVID-19 Vaccine Trial: BRI Team Members Share Their Experience
Without clinical research participants, we might not have groundbreaking cancer treatments like immunotherapy or vaccines for polio, rubella and other life-threatening diseases.

A Quest to Cure Rheumatoid Arthritis
In April 2017, Steve Gordon and his daughter, Callie Triller, hiked to Machu Picchu in Peru. Seven months later, Steve started experiencing severe joint pain and learned he had rheumatoid arthritis (RA).

Operation Shooting Star Helps BRI Fight Autoimmune Disease
Gretchen Schoenstein has dealt with multiple autoimmune diseases — including Hashimoto’s disease and sarcoidosis — for over two decades.